Related Experiment Video
Updated: May 1, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Germline polymorphisms in RNF31 regulate linear ubiquitination and oncogenic signaling
1Institute of Biochemistry II, Goethe University, School of Medicine, Frankfurt am Main, Germany.
Excessive linear ubiquitin chain assembly complex (LUBAC) activity drives cancerous B cell behavior in diffuse large B-cell lymphoma by disrupting NF-κB signaling. Rare RNF31 gene variations and a potential peptide inhibitor were identified.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma.
- Aberrant NF-κB signaling is a hallmark of many B-cell malignancies.
- The linear ubiquitin chain assembly complex (LUBAC) is a key regulator of NF-κB activation.
Purpose of the Study:
- To investigate the role of LUBAC complex hyperactivity in a subtype of DLBCL.
- To identify genetic factors contributing to LUBAC dysregulation.
- To explore therapeutic strategies targeting LUBAC activity.
Main Methods:
- Analysis of B cell samples from DLBCL patients.
- Genetic sequencing to identify mutations in relevant genes.
- In vitro studies using small inhibiting peptides.
Main Results:
- Excessive LUBAC complex activity was found to drive cancerous B cell proliferation in a DLBCL subtype.
- Abnormal NF-κB signaling was directly linked to LUBAC hyperactivity.
- Two rare germline single-nucleotide polymorphisms in the RNF31 gene were identified as causative.
- A small inhibiting peptide demonstrated potential to downregulate LUBAC activity.
Conclusions:
- Hyperactive LUBAC complex, driven by RNF31 polymorphisms, is a key oncogenic driver in a subset of DLBCL.
- Targeting LUBAC offers a potential therapeutic avenue for treating this lymphoma subtype.
- Further research into LUBAC-targeted therapies is warranted.
More Related Videos
09:00Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
Published on: April 17, 2026
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Abnormal Proliferation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...